Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals GAAP effective tax rate by Year
GAAP effective tax rate (%) (%)
Vertex Pharmaceuticals GAAP effective tax rate: 14.9% in FY2025, down 300.6 pts from a year earlier.
Where the FY2025 figure comes from
“|| GAAP effective tax rate | 10.5 | % | 19.7 | % | 14.9 | % | 315.5 | %”
Source: Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗
Reported in Form 8-K EX-99.1 Earnings Releases & Form 10-Q / 10-K Income Tax Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP effective tax rate (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.9% | -300.6 pts | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 315.5% | +298.1 pts | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 17.4% | -4.1 pts | Form 8-K (ex-991_q42024.htm, filed 2025-02-10) ↗ |
| FY2022 | Dec 31, 2022 | 21.5% | +7.3 pts | Form 8-K (ex-991_q42023.htm, filed 2024-02-05) ↗ |
| FY2021 | Dec 31, 2021 | 14.2% | +1.2 pts | Form 8-K (ex-991_q42022.htm, filed 2023-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 13.0% | -1587.0 pts | Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 1,600.0% | – | Form 10-K (filed 2022-02-09) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals GAAP effective tax rate (%), annual FY2019–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/gaap-etr-rel
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.